Aprea Company

Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Technology: Data-driven Technologies
Industry: PharmTech
Headquarters: Stockholm, Stockholms Lan, Sweden
Founded Date: 2003
Employees Number: 11-50
Funding Status: IPO
Investors Number: 2
Total Funding: $5.2M
Estimated Revenue: $1M to $10M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership